What is the Senores Pharmaceuticals Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 6.01% of the total equity shares of Senores Pharmaceuticals Ltd.

What is the Senores Pharmaceuticals Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 10.85% of the total equity shares of Senores Pharmaceuticals Ltd.

How has the Senores Pharmaceuticals Ltd promoter holding changed?

The promoter holding in Senores Pharmaceuticals Ltd changed from 45.82% to 45.82% during the latest reported period.

How has the Senores Pharmaceuticals Ltd FII holding changed?

The FII holding in Senores Pharmaceuticals Ltd changed from 6.62% to 6.01% during the latest reported period.

How has the Senores Pharmaceuticals Ltd DII holding changed?

The DII holding in Senores Pharmaceuticals Ltd changed from 9.77% to 10.85% during the latest reported period.

Who are the major shareholders of Senores Pharmaceuticals Ltd?

The major shareholders of Senores Pharmaceuticals Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Senores Pharmaceuticals Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Senores Pharmaceuticals Ltd public shareholding?

Public shareholders hold 37.33% of the total equity shares of Senores Pharmaceuticals Ltd as per the latest available data.

Senores Pharmaceuticals Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - FormulationsNSE

₹1,215.30

+12.70(+1.06%)

As on 23 Oct 2026 at 15:59

As of 23 Oct 2026 at 15:59, Senores Pharmaceuticals Ltd is trading at ₹1,215.30. The 52-week range stands at ₹706.00–₹1,599.00, with a market cap of ₹5.59 thousand crore. At a P/E of 300.47 and a dividend yield of 0.00%, it is a mid-cap stock in the Pharmaceuticals sector.